Proteon Therapeutics is Pharmaceuticals in United States that focus on rare diseases business. Founded in 2001. They cover business area such as provider, transformative therapy, people, cancer, rare disease, limited treatment option, an investigational cell-base therapy, lymphatic malformation, also an investigational phospholipid substrate replacement therapy, intestinal failure-associate liver disease, patient.
2001
( 23 years old in 2024 )
Rare Diseases
-
200 West Street
Waltham, MA 02451
United States
Private
providertransformative therapypeoplecancerrare diseaselimited treatment optionan investigational cell-base therapylymphatic malformationalso an investigational phospholipid substrate replacement therapyintestinal failure-associate liver diseasepatient
* We use standard office opening hours in near Proteon Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Proteon Therapeutics is Pharmaceuticals business from United States that founded in 2001 (23 years old in 2024), Proteon Therapeutics business is focusing on Rare Diseases.
Proteon Therapeutics headquarter office and corporate office address is located in 200 West Street Waltham, MA 02451 United States.
Proteon Therapeutics was founded in United States.
In 2024, Proteon Therapeutics is currently focus on rare diseases sector.
Above is snippet of Google Trends for "rare diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Proteon Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
